Genetic and pharmacological aspects of histamine H3 receptor heterogeneity

Life Sciences

Volumn 73, Issue 24, 2003, Pages 3043-3072

  Hancock, Arthur A ^a   Esbenshade, Timothy A ^a   Krueger, Kathleen M ^a   Yao, Betty Bei ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 [4 [3 (4 CYCLOPROPANECARBONYLPHENOXY)PROPYL] 1 PIPERAZINYL] 1 PROPANONE; 2 AMINO 1 [4 [3 (4 CYCLOPROPANECARBONYLPHENOXY)PROPYL]PIPERAZIN 1 YL]PROPAN 1 ONE; 2 [4 [3 [4 (CYCLOPROPYLCARBONYLPHENOXY)PROPYL] 1 PIPERAZINYL] 1 METHYL 2 OXOETHYL] 2 FURAMIDE; 4 (4 PHENYLBUTYL) 1H IMIDAZOLE; 4 (6 CYCLOHEXYLHEX 3 ENYL)IMIDAZOLE; 5 CYCLOHEXYL 1 (4 IMIDAZOL 4 YLPIPERIDYL)PENTAN 1 ONE; 5 CYCLOHEXYL 1 [4 (4 IMIDAZOLYL) 1 PIPERIDYL] 1 PENTANONE; A 317920; ADENYLATE CYCLASE; ANTIHISTAMINIC AGENT; CALCIUM CHANNEL; CHEMICAL COMPOUND; CIPROXIFAN; CLOBENPROPIT; DILOXANIDE FUROATE; FUB 349; GT 2227; GT 2331; GUANIDINE DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTAMINE; HISTAMINE AGONIST; HISTAMINE H3 RECEPTOR; IMETIT; IMIDAZOLE DERIVATIVE; IMMEPIP; JB 98064; MITOGEN ACTIVATED PROTEIN KINASE; N (4 CHLOROBENZYL) N (7 PYRROLIDIN 1 YLHEPTYL)GUANIDINE; NEUROTRANSMITTER; RADIOLIGAND; RECEPTOR SUBTYPE; THIOPERAMIDE; UNCLASSIFIED DRUG; VUF 4929;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; BIOASSAY; CORRELATION ANALYSIS; DRUG TARGETING; GENE STRUCTURE; GENETIC VARIABILITY; HUMAN; LIGAND BINDING; MOLECULAR CLONING; MOLECULAR DYNAMICS; NEUROTRANSMISSION; NOMENCLATURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE; RECEPTOR BINDING; SHORT SURVEY; SIGNAL TRANSDUCTION; SPECIES DIFFERENTIATION; TISSUE DISTRIBUTION;

EID: 0141448842     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.06.003     Document Type: Short Survey

References (119)

1. 3 receptor heterogeneity? Behavioral Brain Research. 124:2001;121-127.
2. Anichtchik O.V., Juotari M., Peitsaro N., Mannisto P.T., Panula P. Histamine receptors in the brain of unilaterally 6-OHDA lesioned rats. Abstracts, Society for Neuroscience. 27:2001;. #430.16.
3. Arrang J.-M., Devaux B., Chodkiewicz J.P., Schwartz J.C. H3-receptors control histamine release in human brain. Journal of Neurochemistry. 51:1988;105-108.
4. 3) of histamine receptor. Nature. 302:1983;832-837.
5. 3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations. European Journal of Pharmacology. 188:1990;219-227.
6. Audinot V., Macia C., Coge F., Le Gall A., Guenin S.P., Lockhart B., Lestage P., Galizzi J.P., Boutin J.A. Molecular cloning and pharmacological characterization of the mouse histamine H3 receptor: comparison with the human subtype. Abstracts, Society for Neuroscience. 28:2002;831.1.
7. 3-receptor isoforms. Pharmacologist. 44(Suppl. 1):2002;A196.
8. 3 receptor isoforms. Abstracts, European Histamine Research Society. 2003;35.
9. 3 receptor antagonists act at a single site? European Journal of Pharmacology. 431:2001;215-221.
10. Bertaccini G., Coruzzi G. An update on histamine H3 receptors and gastrointestinal functions. Digestive Disease Sciences. 40:1995;2052-2063.
11. 3 Receptor. 1998;59-111 Elsevier, Amsterdam.
12. Black J.W., Duncan W.A., Durant C.J., Ganellin C.R., Parsons E.M. Definition and antagonism of histamine H2-receptors. Nature. 236(5347):1972;385-390.
13. 3 Receptor. 1998;27-40 Elsevier, Amsterdam.
14. Bockaert J., Pin J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO Journal. 18:1999;1723-1729.
15. 3H]GR168230. European Journal of Pharmacology. 311:1996;305-310.
16. Brown R.E., Stevens D.R., Haas H.L. The physiology of brain histamine. Progress in Neurobiology. 63:2001;637-672.
17. Cassar S. Cloning of the guinea pig H3 receptor. Neuroreport. 11:2000;L3-L4.
18. 3 receptors in the modulation of noradrenaline release from rat spinal cord slices. European Journal of Pharmacology. 287:1995;127-133.
19. 3 receptor-mediated inhibition of excitatory synaptic transmission in the rat dentate gyrus in vivo. Japanese Journal of Pharmacology. 77:1998;251-255.
20. Chen, J., Liu, C., Lovenberg, T.W., 2002. Molecular and pharmacological characterization of the mouse histamine H3 receptor. Submission # AY142145, submitted to GenBank.
21. Chen J., Liu C., Lovenberg T.W. Molecular and pharmacological characterization of the mouse histamine H3 receptor. European Journal of Pharmacology. 467:2003;57-65.
22. 3 receptor subtypes. British Journal of Pharmacology. 107:1992;919-923.
23. 3-receptors in rat cerebral cortical membranes. European Journal of Pharmacology. 114:1995;357-362.
24. 35S]GTPγ[S] binding to pertussis toxin. European Journal of Pharmacology. 296:1996;223-225.
25. 3 receptors regulate ACTH release by AtT-20 cells. European Journal of Pharmacology. 210:1992;31-35.
26. Coge F., Guenin S.P., Audinot V., Renouard-Try A., Beauverger P., Macia C., Ouvry C., Nagel N., Rique H., Boutin J.A., Galizzi J.P. Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochemical Journal. 355:2001;279-288.
27. Coge, F., Rique, H., Levacher, B., Leopold, O., Guenin, S.-P., Boutin, J.-A., Galizzi, J.-P., 2001b. Cloning of mouse histamine H3 receptor. Submitted to the EMBL/GenBank/DDBJ databases.
28. Coruzzi G. II: Histamine H3 receptors and the gastrointestinal tract. Drug Discovery Today. 4:1994;571-572.
29. 3 receptor antagonist. Abstracts of the American Chemical Society Meeting. 2003;. MEDI, #240.
30. 1 receptor. Biochemical and Biophysical Research Communications. 197:1993;1601-1608.
31. DiCarlo G., Ghi P., Orsetti M. Effect of R-(-)-α-methylhistamine and thioperamide on in vivo release of norepinephrine in the rat hippocampus. Progress in Neuropsychopharmacology and Biological Psychiatry. 24:2000;275-284.
32. 3 receptor isoforms with different brain expression and signaling properties. Molecular Pharmacology. 59:2001;1-8.
33. 2+ channels. Journal of Pharmacology and Experimental Therapeutics. 269:1994;221-229.
34. Esbenshade T.A., Krueger K.M., Miller T.M., Kang C.H., Ireland-Denny L.M., Witte D.G., Yao B.B., Faghih R., Bennani Y.L., Williams M., Hancock A.A. Two novel and selective non-imidazole H3 receptor antagonists, A-304121 and A-317920: 1 In vitro pharmacological effects. Journal of Pharmacology and Experimental Therapeutics. 305:2003;887-896.
35. 3 receptors in the inhibitory effect of histamine on serotonin release in the rat brain cortex. Naunyn-Schmiedeberg's Archives of Pharmacology. 342:1990;513-519.
36. 2 receptor. Biochemical and Biophysical Research Communications. 178:1991;1386-1392.
37. George S.R., O'Dowd B.F., Lee S.R. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nature Reviews in Drug Discovery. 1:2002;808-820.
38. Giorgetti M., Bacciottini L., Giovannini M.G., Colivicchi M.A., Goldfarb J., Blandina P. Local GABAergic modulation of acetylcholine release from the cortex of freely moving rats. European Journal of Neuroscience. 12:2000;1941-1948.
39. 3 autoreceptors modulate histamine synthesis through cAMP pathway. Molecular Pharmacology. 61:2002;239-245.
40. Goodearl, A.D.J., 1999. Nucleic acids encoding muscarinic receptors and uses therefore. United States Patent # 5,882,893.
41. Goodearl, A.D.J., Glucksman, M.A., 2000. Methods for detecting nucleic acid molecules encoding a member of the muscarinic family of receptors. United States Patent # 6, 093,545.
42. Goodearl, A.D.J., Glucksman, M.A., Xie, M., Distefano, P., 1999. G-protein coupled receptors and uses therefor. International Patent Application # WO 99/28470.
43. Guenin S.P., Audinot V., Renouard-Try A., Beauverger P., Macia C., Ouvry C., Nagel N., Rique H., Boutin J.A., Galizzi J.P. Genomic organization and characterization of splice variants of the human histamine H3 receptor. Biochemical Journal. 355:2001;279-288.
44. 3 receptor(s) of human cingulate cortex. Inflammation Research. 50(Suppl. 2):2001;S106-S107.
45. 3-receptors in guinea-pig cerebral cortex and ileum longitudinal muscle myenteric plexus. British Journal of Pharmacology. 128:1999;751-759.
46. 3-receptors. British Journal of Pharmacology. 107:1992;347-351.
47. Hough L.B. Genomics meets histamine receptors: new subtypes, new receptors. Molecular Pharmacology. 59(3):2001;415-419.
48. Imamura M., Seyedi N., Lander H.M., Levi R. Functional identification of histamine H3 receptors in the human heart. Circulation Research. 77:1995;206-210.
49. 3 receptors. European Journal of Pharmacology. 133:2001;141-150.
50. Itadani, H., Takimura, T., Nakamura, T., Kobayashi, M., Tanaka K.-I., Hidaka, Y., Ohta, M., 2001. Novel guanosine triphosphate (GTP)-binding protein-coupled receptor protein. European Patent Application, # EP 1, 142, 909, A1.
51. Itadani, H., Takimura, T., Nakamura, T., Kobayashi, M., Tanaka K.-I., Hidaka, Y., Ohta, M., 2002. Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins. United States Patent Application Publication # US 2002/0086359A1.
52. 3-receptor antagonist, [125I]-iodophenpropit, to rat brain. British Journal of Pharmacology. 113:1994;355-362.
53. Karlstedt, K.A., Ahman, M.J., Panula, P., 2001. Histamine H3 receptor expression during rat development and in adult rat peripheral tissues. Abstracts, Society for Neuroscience 27, #378.9.
54. Kidd M., Tang L.H., Miu K., Lawton G.P., Sandor A., Modlin I.M. Autoregulation of enterochromaffin-like cell histamine secretion via the histamine 3 receptor subtype. Yale Journal of Biology and Medicine. 69:1996;9-19.
55. Koyama, M., Seyedi, N., Fung-Leung, W.P., Lovenberg, T.W., Levi, R., 2002. Norepinephrine release from the ischemic heart is greatly enhanced in mice lacking histamine H3 receptors. Submission # NM_133849, submitted to GenBank.
56. Krueger K.M., Kang C.H., Miller T., Witte D., Faghih R., Bennani Y., Esbenshade T.A., Hancock A. Pharmacological properties of the novel histamine H3 receptor antagonist, A-331440. Pharmacologist. 44(Suppl. 1):2002;A196.
57. Laitinen J.T., Hokinen M. Guanosine 5′ -([gamma]-[35S]thio)triphosphate autoradiography allows selective detection of histamine H3 receptor-dependent G protein activation in rat brain tissue sections. Journal of Neurochemistry. 71:1998;808-816.
58. 3-receptors in the inhibition of cholinergic contractile responses of the guinea pig ileum. Journal of Pharmacology and Experimental Therapeutics. 295:2000;607-613.
59. 3 receptor gene is cloned at last. Trends in Pharmacological Sciences. 21:2000;11-12.
60. 3 receptor heterogeneity? Journal of Pharmacology and Experimental Therapeutics. 276:1996;1009-1015.
61. Levi R., Smith N.C.E. Histamine H-3 receptors: a new frontier in myocardial ischemia. Journal of Pharmacology and Experimental Therapeutics. 292:2000;825-830.
62. 3 receptors: role of two amino acids in the third transmembrane domain. British Journal of Pharmacology. 131:2000;1247-1250.
63. Linney I.D., Buck I.M., Harper E.A., Kalindjian S.B., Pether M.J., Shankley N.P., Watt G.F., Wright P.T. Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H3 receptor antagonists. Journal of Medicinal Chemistry. 43:2000;2362-2370.
64. Lintunen M., Karlstedt K., Panula P. Histamine H3 receptor isoform-specific changes in a rat model of epilepsy. Abstracts, Society for Neuroscience. 27:2001;. #755.6.
65. 3 receptor mRNA at the third cytoplasmic loop is not detectable in humans. Molecular Brain Research. 83:2000;145-150.
66. Lovenberg, T.W., Erlander, M., Huvar, A., Pyati, J., 2000. DNA encoding a human histamine receptor of the H3 subtype. United States Patent #6,136, 559.
67. Lovenberg, T.W., Erlander, M., Huvar, A., Pyati, J., 2002. DNA encoding a human histamine receptor of the H3 subtype. United States Patent # 6,413,743B1.
68. 3 receptor reveals distinct species pharmacological profiles. Journal of Pharmacology and Experimental Therapeutics. 293:2000;771-778.
69. 3 receptor. Molecular Pharmacology. 55:1999;1101-1107.
70. Maggio R., Barbier P., Colelli A., Salvadori F., Demontis G., Corsini G.U. G protein-linked receptors: pharmacological evidence for the formation of heterodimers. Journal of Pharmacology and Experimental Therapeutics. 291:1999;251-257.
71. Molderings G.J., Weissenborn G., Schlicker E., Likungu J., Goethert M. Inhibition of noradrenaline release the sympathetic nerves of the human saphenous vein by presynaptic histamine H3 receptors. Naunyn-Schmiedberg's Archives of Pharmacology. 346:1992;46-50.
72. 3 receptors regulates histamine neurons in brain. Nature. 408:2000;860-864.
73. Morisset S., Sasse A., Gbahou F., Heron A., Ligneau X., Tardivel-Lacombe J., Schwartz J.-C., Arrang J.-M. The rat H3 receptor: gene organization and multiple isoforms. Biochemical and Biophysical Research Communications. 280:2001;75-80.
74. Nakamura T., Itadani H., Hidaka Y., Ohta M., Tanaka K. Molecular cloning and characterization of a new human histamine receptor. HH4R. Biochemical and Biophysical Research Communications. 279:2000;615-620.
75. Oda T., Matsumoto S.-I., Masuho Y., Takasaki J., Matsumoto M., Hamohara M., Saito T., Ohishi T., Soga T., Hiyama H., Matsushime H., Furuichi K. cDNA cloning and characterization of porcine histamine H4 receptor. Biochimica Biophysica Acta. 1575:2002;135-138.
76. Oda T., Morikawa N., Saito Y., Masuho Y., Matsumoto S. Molecular cloning and characterization of novel type of histamine receptor preferentially expressed in leukocytes. Journal of Biological Chemistry. 47:2000;36781-36786.
77. Pillot C., Heron A., Cochois V., Tardivel-Lacombe J., Ligneau X., Schwartz J.-C., Arrang J.-M. A detailed mapping of the histamine H3 receptor and its gene transcripts in rat brain. Neuroscience. 114:2002;173-193.
78. 1 receptor-mediated effects in the guinea-pig isolated duodenum. Inflammation Research. 50(Suppl. 2):2001;S110-S111.
79. Prast H., Tran M.H., Fischer H., Kraus M., Lamberti C., Grass K., Philippu A. Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H3 histamine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 360:1999;558-564.
80. Prinz C., Kajimura M., Scott D.R., Mercier F., Helander H.F., Sachs G. Histamine secretion from rat enterochromaffinlike cells. Gastroenterology. 105:1993;449-461.
81. 3 receptors. British Journal of Pharmacology. 135:2002;383-392.
82. 3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn-Schmiedeberg's Archives of Pharmacology. 345:1992;489-493.
83. 3 receptor heterogeneity? Naunyn-Schmiedeberg's Archives of Pharmacology. 353:1996;482-488.
84. 3 heteroreceptors. Fundamental and Clinical Pharmacology. 8:1994;128-137.
85. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., Ruat M. Histaminergic transmission in the mammalian brain. Physiological Reviews. 71:1991;1-51.
86. 3 receptor. European Neuropsychopharmacology. 11:2001;441-448.
87. 3 receptor heterogeneity. Naunyn-Schmiedeberg's Archives of Pharmacology. 350:1994;375-379.
88. Selbach O., Brown R.E., Haas H.L. Long-term increase of hippocampal excitability by histamine and cyclic AMP. Neuropharmacology. 36:1997;1539-1548.
89. Silver R.B., Mackins C.J., Smith N.C.E., Koritchneva I.L., Lefkowitz K., Lovenberg T.W., Levi R. Coupling of histamine H-3 receptors to neuronal Na+/H+ exchange: a novel protective mechanism in myocardial ischemia. Proceedings of the National Academy of Sciences USA. 98(5):2001;2855-2859.
90. Silver R.B., Poonwasi K.S., Seyedi N., Wilson S.J., Lovenberg T.W., Levi R. Decreased intracellular calcium mediates the histamine H-3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings. Proceedings of the National Academy of Sciences USA. 99:2002;501-506.
91. Stark H., Purand K., Huels A., Ligneau X., Garbarg M., Schwartz J.-C., Schunack W. [125]Iodoproxyfan and related compounds: a reversible radioligand and novel classes of antagonists with high affinity and selectivity for the histamine H3 receptor. Journal of Medicinal Chemistry. 39:1996;1220-1226.
92. Takashita Y., Watanabe T., Sakata T., Munakata M., Ishibashi H., Akaike N. Histamine modulates high-voltage-activated calcium channels in neurons dissociated from the rat tuberomammilary nucleus. Neuroscience. 87:1998;797-805.
93. 3 receptor: evidence for two isoforms. Neuroreport. 11:2000;755-759.
94. 3 receptor gene. Neuroreport. 12:2001;321-324.
95. 3 receptor antagonist: in vitro and in vivo studies. Journal of Pharmacology and Experimental Therapeutics. 275:1995;598-604.
96. 3 gene variant-1. International Patent Application WO01/68665A1.
97. 3 gene variant-3. International Patent Application WO01/68816A1.
98. 3 gene variant-2. United States Patent #: 6,355,452 B1
99. Uveges A.J., Kowal D., Zhang Y., Spangler T.B., Dunlop J., Semus S., Jones P.G. The role of transmembrane helix 5 in agonist binding to the human H3 receptor. Journal of Pharmacology and Experimental Therapeutics. 301:2002;451-458.
100. 3 receptors in human saphenous vein and guinea pig ileum. European Journal of Pharmacology. 366:1999;73-78.
101. Vollinga R.C., de Koning J.P., Jansen F.P., Leurs R., Menge W.M., Timmerman H. A new potent and selective histamine H3 receptor agonist, 4-(1H-imidazol-4-ylmethyl)piperidine. Journal of Medicinal Chemistry. 37:1994;332-333.
102. 3 receptor. Neuropharmacology. 42:2002;929-940.
103. Wellendorph P., Goodman M.W., Nash N.R., Weiner D.M. Molecular cloning and expression of functionally distinct isoforms of the human H3 receptor. Abstracts, International Sendai Histamine Symposium # O-9:2000.
104. 3H]Nα-methylhistamine binding differ from that of rodents. European Journal of Pharmacology. 377:1999;233-239.
105. 3H]methylhistamine binding to the rat brain H3 histamine receptor. Journal of Neurochemistry. 55:1990;1612-1616.
106. 3-histamine receptor subtypes. Molecular Pharmacology. 38:1990;610-613.
107. Wiedemann P., Bonisch H., Oerters F., Bruss M. Structure of the human histamine H-3 receptor gene (HRH3) and identification of naturally occurring variations. Journal of Neural Transmission. 109:2002;443-453.
108. 3 antagonists. Journal of Pharmacology and Experimental Therapeutics. 299:2001;908-914.
109. Willems E., Knigge U., Jorgensen H., Kjaer A., Warberg J. Effect of blockade of postsynaptic H1 or H2 receptors or activation of presynaptic H3 receptors on catecholamine-induced stimulation of ACTH and prolactin secretion. European Journal of Endocrinology. 142:2000;637-641.
110. Witte, D., Esbenshade, T.A., Hancock, A.A., Yao, B.B., 2003. The canine histamine receptor H3 (HRH3) partial cDNA sequence, codons 1 and 2 for partial sequence. Submissions # AY231165 and AY231166, submitted to GenBank.
111. Wulff B.S., Hastrup S., Rimvall K. Characteristics of recombinantly expressed rat and human histamine H-3 receptors. European Journal of Pharmacology. 453:2002;33-41.
112. + channels to hyperpolarize magnocellular histaminergic neurons of rat posterial hypothalamus. Abstracts, Society for Neuroscience. 17:1991;409.
113. 3 histamine receptors. Abstracts, Society for Neuroscience. 27:2001;. #804.9.
114. Yao B.B., Hutchins C.W., Carr T.L., Cassar S., Miller T.R., Kang C.H., Black L.A., Faghih R., Bennani Y.L., Esbenshade T.A., Hancock A.A. Molecular modeling and pharmacological analysis of species-related histamine H3 receptor heterogeneity. Neuropharmacology. 44:2003;773-786.
115. 3 receptor. European Journal of Pharmacology. 2003;. submitted.
116. 3R) antagonists. Abstracts, European Histamine Research Society. 2002;46.
117. Yates S.L., Babu J.S., Gallagher M.J., Jacoway Y., Pawlowski G., Tedford C.E. Cloning and expression of novel isoforms of the human histamine H3 receptor. Abstracts, Society for Neuroscience. 27:2001;804.3.
118. Yates S.L., Powlowski G.P., Babu J.S., Rajagopalan R., Wawro W.J., Tedford C.E. Inverse agonists of the histamine-3- receptor as appetite suppressants. Abstracts, American Chemical Society MEDI-2. 2003.
119. 3 receptors on myenteric cholinergic neurons. Gastoenterology. 106(Suppl):1994;A591.